Immunogenetic Manifestations of Lyme Borreliosis / Imūnìenģtiskās Izpausmes Laimboreliozes Gadījumā

Kovaļčuka, Lilija; Eglīte, Jeļena; Zīālīte, Māra; Lucenko, Irina; Vīksna, Ludmila; Krūmiņa, Angelika

doi:10.1515/prolas-2016-0034

Abstract

In this study, we sought to identify human leukocyte antigen (HLA) DRB1 alleles that might be associated with Lyme borreliosis in Latvian patients. Case patients and control subjects were similar in age, sex, and ethnic heritage and differed only in the presence of Borrelia burgdorferi infection. The frequency of HLA-DRB1*07 (OR 3.52; p = 0.001), HLA-DRB1*15 (OR 3.02; p = 0.001) and HLA-DRB1 *17 (03) (OR 2.63; p = 0.001) were significantly increased in the Lyme disease patients compared with the control groups. The frequency of the alleles -DRB1*11(OR 0.37; p = 0.005) and -DRB1*13 (OR 0.34; p = 0.002) was smaller in Borreliosis patients and significantly higher in the control group.

References

Abramowicz, M. (2000). Treatment of Lyme disease. Med. Letter, 42, 37-39.
Search in Google Scholar
Anonymous (2008). Reported Cases of Lyme Disease by Year, 2007, United States, 1991-2006. September 27, 2007 (cited 2008 March 26); Available at: http://www.cdc.gov/ncidod/dvbid/lyme/ld_UpClimbLymeDis.htm.
Search in Google Scholar
Anonymous (2012). Categorical data analysis using the SAS system.
Search in Google Scholar
Anonymous (2014). Statistical data on incidence of infectious diseases in Latvia 2014. Available at: http://www.ecdc.europa.eu/en/publications/publications/tbe-in-euefta. pdf (accessed 03.06.2016).
Search in Google Scholar
Auwaerter, P. G., Aucott, J., Dumler, J. S. (2004). Lyme borreliosis (Lyme disease): Molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment. Expert Rev. Mol. Med., 6 (2), 1-22.10.1017/S1462399404007276
Search in Google Scholar
Auwaerter, P. G. (2007). Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to Lyme disease. Clin. Infect. Dis., 45 (2), 143-148.10.1086/518854
Search in Google Scholar
Bateman, H., Sigal, L. (2000). Update on Lyme Carditis. Curr. Infect. Dis. Rep., 2 (4), 299-301.10.1007/s11908-000-0006-z
Search in Google Scholar
Bunikis, J., Barbour, A. G. (2002). Laboratory testing for suspected Lyme disease. Med. Clin. North Amer., 86 (2), 311-340.10.1016/S0025-7125(03)00089-0
Search in Google Scholar
Fallon, B. A., Keilp, J. G., Corbera, K. M., Petkova, E., Britton, C. B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D. R., Sackeim, H. A. (2008). A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology, 70 (13), 992-1003.10.1212/01.WNL.0000284604.61160.2d17928580
Search in Google Scholar
Feder, H. M. Jr, Johnson, B. J. B., O’Connell, S., Shapiro, E. D., Steere, A. C., Wormser, G. P. (2007). The Ad Hoc International Lyme Disease Group. A critical appraisal of Chronic Lyme Disease. New Engl. J. Med., 357, 1422-1430.10.1056/NEJMra07202317914043
Search in Google Scholar
Fleming, R. V., Marques, A. R., Klempner, M. S., Schmid, C. H., Dally, L. G., Martin, D. S., Philipp, M. T. (2004). Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis., 23 (8), 615-618.10.1007/s10096-004-1163-z15243815
Search in Google Scholar
Halperin, J. J. (2003). Lyme disease and the peripheral nervous system. Muscle Nerve, 28 (2), 133-143.10.1002/mus.1033712872317
Search in Google Scholar
Halperin, J. J. (2005). Central nervous system Lyme disease. Curr. Neurol. Neurosci. Rep., 5 (6), 446-452.10.1007/s11910-005-0032-116263055
Search in Google Scholar
Halperin, J. J, Shapiro, E. D., Logigian, E., Belman, A. L., Dotevall, L., Wormser, G. P., Krupp, L., Gronseth, G., Bever, C. T. Jr. (2007). Practice parameter: Treatment of nervous system Lyme disease (An evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 69, 91-102.10.1212/01.wnl.0000265517.66976.2817522387
Search in Google Scholar
Hu, L. (2005). Lyme arthritis. Infect. Dis. Clin. North Amer., 19 (4), 947-961.10.1016/j.idc.2005.07.007
Search in Google Scholar
Klitz, W., Maiers, M., Spellman, S., Baxter-Lowe, L. A., Schmeckpeper, B., Williams, T. M., Fernandez-Vina, M. (2003). New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens. 62, 296-307.10.1034/j.1399-0039.2003.00103.x
Search in Google Scholar
Kotsch, K., Wehling, J., Blasczyk, R. (1999). Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: Sequencing based typing of HLA-DRB genes. Tissue Antigens, 53, 486-497.10.1034/j.1399-0039.1999.530505.x
Search in Google Scholar
Mullegger, R. R. (2004). Dermatological manifestations of Lyme borreliosis. Eur. J. Dermatol., 14, 296-309.
Search in Google Scholar
Nadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Aguero-Rosenfeld, M. E., Dennis, D. T., Wormser, G. P. (2001). Tick Bite Study Group. Prophylaxis with single- dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New Engl. J. Med., 345, 79-84.10.1056/NEJM200107123450201
Search in Google Scholar
Nowakowski, J., Nadelman, R. B., Sell, R., McKenna, D., Cavaliere, L. F., Holmgren, D., Gaidici, A., Wormser, G. P. (2003). Long-term follow- up of patients with culture-confirmed Lyme disease. Amer. J. Med., 115, 91-96.10.1016/S0002-9343(03)00308-5
Search in Google Scholar
Olerup, O., Aldener, A., Fogdell, A. (1993). HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP). Tissue Antigens, 41 (3), 119-134.10.1111/j.1399-0039.1993.tb01991.x
Search in Google Scholar
Oksi, J., Nikoskelainen, J., Hiekkanen, H., Lauhio, A., Peltomaa, M., Pitkäranta, A., Nyman, D., Granlund, H., Carlsson, S. A., Seppälä, I., Valtonen, V., Viljanen, M. (2007). Duration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study. Eur. J. Clin. Microbiol. Infect. Dis., 26, 571-581.10.1007/s10096-007-0340-2
Search in Google Scholar
Philipp, M. T., Wormser, G. P., Marques, A. R., Bittker, S., Martin, D. S., Nowakowski, J.,. Dally, L. G. (2005). A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin. Diagn. Lab. Immunol., 12 (9), 1069-1074.
Search in Google Scholar
Piacentino, J..D., Schwartz, B. S. (2002). Occupational risk of Lyme disease: An epidemiological review. Occup. Environ. Med., 59 (2), 75-84.10.1136/oem.59.2.75
Search in Google Scholar
Qureshi, M. Z., New, D., Zulqarni, N. J., Nachman, S. (2002). Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J., 21, 12-14.10.1097/00006454-200201000-00003
Search in Google Scholar
Schoen, R. T., Sikand, V. K., Caldwell, M. C., Van Hoecke, C., Gillet, M., Buscarino, C., Parenti, D. L. (2000). Safety and immunogenicity profile of a recombinant outer surface protein A Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months. Clin. Therapeutics, 22, 315-325.10.1016/S0149-2918(00)80035-1
Search in Google Scholar
Seltzer, E. G., Gerber, M. A., Cartter, M. L., Freudigman, K., Shapiro, E. D. (2000). Long-term outcomes of persons with Lyme disease. The Journal of the American Medical Association (JAMA), 283, 609-616.10.1001/jama.283.5.609
Search in Google Scholar
Sikand, V. K., Halsey, N., Krause, P. J., Sood, S. K., Geller, R., Van Hoecke, C., Buscarino, C., Parenti, D. (2001). Pediatric Lyme Vaccine Study Group. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in healthy children and adolescents:Arandomized controlled trial. Pediatrics, 108, 123-128.10.1542/peds.108.1.123
Search in Google Scholar
Smith, R. P., Schoen, R. T., Rahn, D. W., Sikand, V. K., Nowakowski, J., Parenti, D. L., Holman, M. S., Persing, D. H., Steere, A. C. (2002). Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med., 136, 421-428.10.7326/0003-4819-136-6-200203190-00005
Search in Google Scholar
Steere, A. C. (2001). Lyme disease. New Engl. J. Med., 345, 115-125.10.1056/NEJM200107123450207
Search in Google Scholar
Steere, A. C., Gross, D, Meyer, A. L., Huber, B. T. (2001). Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun., 16, 263-268.10.1006/jaut.2000.0495
Search in Google Scholar
Steere A. C., Dhar. A, Hernandez, J., Fischer, P. A., Sikand, V. K., Schoen, R. T., Nowakowski, J., McHugh, G., Persing, D. H. (2003). Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Amer. J. Med., 114, 58-62.10.1016/S0002-9343(02)01440-7
Search in Google Scholar
Steere, A. C., Falk, B., Drouin, E. E., Baxter-Lowe, L. A., Hammer, J., Nepom, G. T. (2003). Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum., 48, 534-540.10.1002/art.1077212571864
Search in Google Scholar
Steere, A. C., McHugh, G., Suarez, C., Hoitt, J., Damle, N., Sikand, V. K. (2000). Prospective study of coinfection in patients with erythema migrans. Clin. Infect. Dis., 36, 1078-1081.10.1086/36818712684924
Search in Google Scholar
Steere, A. C., Klitz ,W., Drouin, E. E., Falk, B. A., Kwok, W. W., Nepom, G. T. Baxter-Lowe, L. A. (2006). Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J. Exp. Med., 203, 961-971.10.1084/jem.20052471321272516585267
Search in Google Scholar
Stricker, R. B. (2007). Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin. Infect. Dis., 45, 149-157.10.1086/51885317578772
Search in Google Scholar
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., Nadelman, R. B. (2006). The clinical assessment, treatment and prevention of Lyme disease, human granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis., 43, 1089-1134.10.1086/50866717029130
Search in Google Scholar
Wormser, G. P., Nadelman, R. B., Dattwyler, R. J., Dennis, D. T., Shapiro, E. D., Steere, A. C., Rush, T. J., Rahn, D. W., Coyle, P. K., Persing, D. H., Fish, D., Luft, B. J. (2000). Infectious Diseases Society of America Practice Guidelines for the Treatment of Lyme Disease. Clin. Infect. Dis., 31 (Suppl 1), S1-S14. (also available at: www.idsociety.org).
Search in Google Scholar
Wormser, G. P., Ramanathan, R., Nowakowski, J., McKenna, D., Holmgren, D., Visintainer, P., Dornbush, R., Singh, B., Nadelman, R. B. (2003). Duration of antibiotic therapy for early Lyme disease: A randomized, double- blind, placebo-controlled trial. Ann. Intern. Med., 138, 697-704. 10.7326/0003-4819-138-9-200305060-0000512729423
Search in Google Scholar

Immunogenetic Manifestations of Lyme Borreliosis / Imūnìenģtiskās Izpausmes Laimboreliozes Gadījumā

Abstract

Paradigm

My account